Lupaneta Lyophilisate For Suspension For Injection 11.25-5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Lupaneta: Lyophilisate for suspension for injection (11.25-5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

LEUPROLIDE; NORETHINDRONE (loo PROE lide; nor eth IN drone) is a combination of 2 medicines that help to treat endometriosis in women. Leuprolide is an injection that acts like a natural hormone in the body. Norethindrone is a tablet that is a female hormone.

In-Depth Information

Lupaneta Pack 3-Month 11.25mg-5mg Kit

NDC: 000741053
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Endometriosis

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Lupaneta Pack 3-Month 11.25mg-5mg Kit

Reported Side Effects for Lupaneta Pack 3-Month 11.25mg-5mg Kit

Migraine Incidence:
<51.0%*
Severity: MODERATE
Onset: EARLY
Vomiting Incidence:
<29.0%*
Severity: MILD
Onset: EARLY
Broken Bones Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Memory Incidence:
2.0-4.0%*
Severity: MODERATE
Onset: DELAYED
Paresthesias Incidence:
3.0-9.0%*
Severity: MILD
Onset: DELAYED
Injection Site Reaction Incidence:
3.0-9.0%*
Severity: MILD
Onset: RAPID
Muscle Cramps Incidence:
3.0-9.0%*
Severity: MILD
Onset: DELAYED
Weight Gain Incidence:
4.0-13.0%*
Severity: MILD
Onset: DELAYED
Nervousness Incidence:
4.0-11.0%*
Severity: MILD
Onset: DELAYED
Depression Incidence:
4.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
4.0-7.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
4.0-7.0%*
Severity: MILD
Onset: EARLY
Decreased Sexual Desire Incidence:
4.0-7.0%*
Severity: MILD
Onset: DELAYED
Acne Incidence:
5.0-18.0%*
Severity: MILD
Onset: DELAYED
Hair Loss Incidence:
5.0-18.0%*
Severity: MILD
Onset: DELAYED
Fluid Retention Incidence:
7.0-9.0%*
Severity: MODERATE
Onset: DELAYED
Swelling Incidence:
7.0-9.0%*
Severity: MODERATE
Onset: DELAYED
Balance Problems Incidence:
7.0-11.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
7.0-11.0%*
Severity: MILD
Onset: EARLY
Breast Pain Incidence:
8.0-13.0%*
Severity: MILD
Onset: DELAYED
Vaginal Infection Incidence:
8.0-15.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
10.0-15.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
10.0-15.0%*
Severity: MODERATE
Onset: DELAYED
No Menstrual Periods Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
Weakness Incidence:
11.0-18.0%*
Severity: MILD
Onset: DELAYED
Inability To Sleep Incidence:
13.0-15.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
13.0-29.0%*
Severity: MILD
Onset: EARLY
Emotional Lability Incidence:
27.0-34.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
46.0-51.0%*
Severity: MILD
Onset: EARLY
Hot Flashes Incidence:
57.0-87.0%*
Severity: MODERATE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

SECOND Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

THIRD Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Lupaneta

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5